Celyad Oncology SA (CLYYF)
0.30
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Celyad Oncology EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -0.2982 |
| March 31, 2022 | -0.3815 |
| December 31, 2021 | -0.2402 |
| September 30, 2021 | -0.5542 |
| Date | Value |
|---|---|
| June 30, 2021 | -0.4941 |
| March 31, 2021 | -0.7351 |
| December 31, 2020 | 0.4173 |
| September 30, 2020 | -0.4561 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.7351
Minimum
Mar 2021
0.4173
Maximum
Dec 2020
-0.3428
Average
-0.4188
Median
EPS Diluted (Quarterly) Benchmarks
| Galapagos NV | 1.488 |
| UCB SA | -- |
| Mithra Pharmaceuticals SA | -- |
| Nyxoah SA | -0.4508 |
| MDxHealth SA | -0.31 |